Capital Raising and Growth Capital 2026: Capital Is Available, But Structure Matters

Private capital markets in 2026 are open, but they are not indiscriminate. Large pools of capital remain active across growth equity, private equity, family offices, strategic investors, private credit, and bank lending. At the same time, the market is rewarding companies that can explain exactly why capital is needed, how it will be used, what evidence supports the plan, and how the proposed structure affects control, dilution, covenants, and future strategic alternatives.

Palmstone Capital's view is that a capital raise should be treated as a strategic transaction, not an administrative funding exercise. A founder raising expansion capital, a shareholder considering partial liquidity, a sponsor-backed company funding acquisitions, and a board evaluating structured capital all face different tradeoffs. The right answer depends on business quality, timing, risk appetite, governance preferences, and the range of available alternatives.

This report is written for founders, shareholders, management teams, boards, private equity sponsors, family offices, strategic investors, and capital providers. It connects current market signals with practical decision points: when to use growth capital advisory, when a broader capital raising advisory process is appropriate, when debt financing may be preferable, and when a minority recapitalization or full sale should be compared before capital is raised.

A capital raise should begin with the problem being solved. Companies raise capital for geographic expansion, sales investment, product development, acquisition funding, working capital, refinancing, balance-sheet flexibility, shareholder liquidity, or strategic partnership. Those objectives are not interchangeable. A capital provider evaluating acquisition funding will ask different questions than an investor funding sales expansion or a lender supporting refinancing.

Use of proceeds matters because it translates capital need into an underwriting case. If a company says it needs growth capital, the investor will want to know what changes after funding. Does the company hire a larger sales team, enter new markets, acquire smaller targets, build product capability, expand infrastructure, or reduce customer concentration? The answer should be visible in the financial model, milestones, hiring plan, operating metrics, and governance expectations.

Shareholder liquidity should also be separated from company capital. A founder may want partial liquidity while the business needs capital for growth. Both can be valid, but they should be presented clearly because investors price primary capital and secondary liquidity differently. A process that blurs those objectives can create avoidable negotiation pressure later, especially if the investor believes proceeds are being used to de-risk shareholders rather than strengthen the business.

The capital provider universe is broader than a simple choice between selling equity and borrowing money. Growth equity funds may support expansion without requiring control. Private equity sponsors may provide minority or control capital depending on mandate and shareholder objectives. Family offices can offer patient capital and flexible ownership horizons. Strategic investors may contribute market access, customers, technology, or distribution. Private credit funds and banks may provide debt, unitranche facilities, acquisition financing, or refinancing alternatives.

McKinsey's 2026 private equity research points to strong activity in larger buyout and growth transactions, while also highlighting the increasing importance of differentiated capital channels and scaled managers. Bain's 2026 private equity report describes a market with renewed deal and exit activity, but also a narrow recovery and continued pressure on distributions. For companies seeking capital, the practical message is that investor appetite exists, but the market is selective about quality, scale, and the durability of the value-creation plan.

The right universe should be built around fit, not maximum volume. A software company with recurring revenue, high retention, and efficient growth may attract growth equity and technology-focused sponsors. A family-owned industrial business with predictable cash flow may be better suited to family offices, strategic capital, or debt-supported recapitalization. A healthcare services company may need investors comfortable with reimbursement, regulation, clinical quality, and labor risk. Sector fit affects valuation, diligence, governance, and closing certainty.

The 2026 backdrop is supportive enough for companies to pursue capital, but still selective enough that preparation matters. KPMG's 2026 global M&A research describes improving activity alongside structural complexity, including regulatory volatility, portfolio simplification, and diverging risk appetite between buyers. PwC similarly describes a more polarised market in which large transactions and well-capitalised buyers are driving much of the headline momentum. These signals matter for capital raising because investors compare private placements against acquisitions, exits, public markets, and internal portfolio needs.

Public-market access is also selective. EY's Q1 2026 IPO analysis describes resilient but more demanding markets, with investor focus concentrating around larger, scaled issuers and companies that can demonstrate clear value creation. For private companies, that reinforces the importance of optionality. A company that is not ready for public markets may still raise private capital, but private investors will ask many of the same questions about scale, governance, reporting quality, growth durability, and market timing.

Debt conditions add another layer. The Federal Reserve's April 2026 loan officer survey reported tighter standards for commercial and industrial loans, while the European Central Bank's first-quarter 2026 bank lending survey reported net tightening of credit standards for loans to firms. This does not mean borrowers cannot finance acquisitions, refinancing, or growth. It means debt capacity should be tested early through private credit, bank lending, direct lending, structured capital, and downside-case analysis rather than assumed late in a process.

Equity capital can support growth without scheduled debt service, which can be useful when investment returns take time or when cash flow needs flexibility. The cost is dilution and governance. Debt preserves ownership, but it introduces fixed obligations, covenants, security, information requirements, and refinancing considerations. Structured capital can sit between those alternatives, but may include preferred returns, warrants, redemption rights, covenants, or other features that change economics over time.

A company should not choose an instrument only because it is available. The instrument should fit the cash-flow profile, risk level, use of proceeds, and shareholder objectives. Recurring-revenue companies may support different leverage than project-based services firms. Asset-heavy businesses may have collateral options that software companies do not. Cyclical companies may need more covenant cushion than companies with stable contracted revenue. Capital structure should match the operating reality.

The direct lending vs bank financing distinction is particularly important in 2026. Direct lenders may provide speed, flexibility, unitranche capacity, delayed-draw facilities, and acquisition financing. Banks may offer lower pricing for the right credit, but often require stronger reporting, covenant discipline, and relationship context. Private credit can be useful, but the Financial Stability Board's 2026 work on private credit vulnerabilities is a reminder that lender scrutiny and data quality still matter.

A high headline valuation can be attractive, but it does not automatically create the best shareholder outcome. Capital raising terms may include liquidation preferences, participation rights, anti-dilution protection, redemption rights, board seats, veto rights, information rights, transfer restrictions, drag rights, tag rights, and exit provisions. These terms can materially affect downside protection, control, future financing flexibility, and eventual proceeds to shareholders.

Founders and shareholders should compare offers on net economics, not just price. A lower valuation with cleaner terms may be preferable to a higher valuation with aggressive preferences or governance constraints. Conversely, a premium investor may be worth accepting if the capital provider adds sector expertise, acquisition capability, customer access, or future financing support that improves the probability of value creation.

The same principle applies when comparing a capital raise with a sale or recapitalization. A company valuation discussion should distinguish enterprise value, equity value, dilution, debt-like items, rollover exposure, and deferred consideration. Shareholders evaluating partial liquidity should also understand founder liquidity options, rollover equity, and deal structures for shareholders before accepting a term sheet.

A minority recapitalization can be useful when shareholders want liquidity and support without selling control. It can allow a founder to de-risk personal wealth, bring in a partner, fund growth, or prepare for a later exit. It can also create complexity: governance rights, reporting obligations, future exit expectations, investor protections, and potential tension between current liquidity and future control.

A board or founder should compare minority capital against a broader set of strategic alternatives. A full sale may provide greater immediate liquidity and transfer more execution risk. A dividend recapitalization may preserve ownership but increase leverage. Growth equity may fund expansion but dilute ownership. Strategic capital may support commercial goals but narrow future options. Continued independence may be best if the company is not ready or if available terms do not compensate shareholders for the obligations created.

The practical question is not whether minority capital is fashionable. It is whether the structure improves the company's risk-adjusted path. Palmstone's resources on minority recapitalization, dividend recapitalization, and preparing a business for sale help shareholders compare liquidity, control, valuation, debt capacity, and future strategic alternatives before the market frames the answer for them.

A capital raising process will expose the quality of a company's reporting, forecast, governance, and operating narrative. Investors and lenders will test revenue quality, gross margin durability, customer concentration, churn, retention, backlog, pipeline, cash conversion, working capital, capital expenditure requirements, tax matters, legal issues, management depth, and use-of-proceeds logic. The more complex the structure, the more important preparation becomes.

A credible financial model is not a spreadsheet built for optimism. It should show historical performance, bridge adjusted EBITDA or operating profit, explain assumptions, present downside cases, and connect capital use to measurable outcomes. If acquisition funding is part of the plan, the model should show how targets will be sourced, financed, integrated, and measured. If shareholder liquidity is part of the plan, the model should separate company capital from secondary proceeds.

Preparation also includes diligence materials. A well-built data room checklist, credible quality of earnings analysis, and disciplined management presentation can reduce friction and improve confidence. These materials do not guarantee terms, but they help investors and lenders evaluate the business on evidence rather than uncertainty.

This framework applies when a company is considering growth capital, private placements, structured capital, minority liquidity, acquisition financing, refinancing, or a broader strategic alternatives review. It is especially relevant when shareholders are deciding whether to raise capital, sell the company, pursue a recapitalization, or continue independently for another cycle.

It may be less relevant where the capital need is very small, can be met through an existing facility, or does not affect governance, dilution, control, or strategic options. It may also be premature where the company lacks reliable financial information, has unresolved operational issues, or cannot yet explain how proceeds will create value. In those situations, preparation may be more valuable than immediate outreach.

The most important discipline is sequencing. Define the objective first, prepare the evidence second, choose the relevant capital universe third, and negotiate structure only after alternatives are understood. That sequence helps management and shareholders avoid accepting a proposal that solves a short-term capital need while creating long-term constraints.

Capital raising is strongest when it creates informed choice. A single investor conversation can be useful, but it rarely proves market terms. A broad process can create more options, but it must be targeted enough to protect confidentiality and management time. The right process design depends on the company's objectives, readiness, timeline, sector, shareholder alignment, and need for discretion.

Palmstone Capital advises clients across the transaction lifecycle: sale preparation, buy-side acquisitions, capital raises, debt financings, recapitalizations, and strategic alternatives. In a capital raising context, that means helping management and shareholders compare investor universe, capital structure, valuation support, lender appetite, governance terms, and the practical effect of each alternative after closing.

For many companies, the decision is not simply whether to raise capital. It is whether capital is the best route compared with a sale, acquisition program, refinancing, dividend recapitalization, minority recapitalization, or continued independence. A confidential conversation can help clarify which path deserves preparation before the market is approached.